Results 41 to 50 of about 1,900 (132)

LA INDUSTRIA FARMACÉUTICA ESPAÑOLA: ANÁLISIS MEDIANTE LA PERSPECTIVA DE GRUPOS ESTRATÉGICOS 2000-2003

open access: yesRevista Visión Gerencial, 2007
La industria farmacéutica española ha sufrido una importante transformación durante los últimos años. Para sobrevivir a estas nuevas condiciones de mercado, las empresas han redimensionado sus estrategias competitivas hacia actividades de Investigación ...
Enzo Piña
doaj  

Advances in Microfluidic‐Based Core@Shell Nanoparticles Fabrication for Cancer Applications

open access: yesAdvanced Healthcare Materials, Volume 13, Issue 23, September 13, 2024.
Microfluidic (MF) devices may become standard for CSNP formulation in cancer therapy, allowing precise control over the properties of nanocarriers. Precise nanofabrication pushes the boundaries in clinical research, as otherwise unstable anticancer agents now become viable for clinical practice.
Duarte R. S. Almeida   +6 more
wiley   +1 more source

Medicamentos com defeitos estão entre nós! Umaanálise do combate aos defeitos em embalagens demedicamentos à luz do Direito Administrativo Sanitárioe do Consumidor

open access: yesVigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia
Introdução: Disponibilizar medicamento com qualidade, seguro e eficaz é a finalidade da cadeia de produção e suprimento, entretanto, erros ocorrem.
Alexandre Figueredo   +2 more
doaj   +1 more source

Oportunidades na indústria de medicamentos e a lógica do desenvolvimento local baseado nos biomas brasileiros: bases para a discussão de uma política nacional [PDF]

open access: yesCadernos de Saúde Pública, 2007
Este trabalho traz para a Saúde Pública a discussão de novos conceitos sobre o desenvolvimento tecnológico de medicamentos de origem vegetal, constatando as oportunidades no mercado da indústria farmacêutica tanto para a produção de medicamentos ...
Glauco de Kruse Villas Bôas   +1 more
doaj  

First‐line tagraxofusp induces durable responses with prolonged survival in adults younger than 50 years with blastic plasmacytoid dendritic cell neoplasm: Post hoc analysis of a phase 2 trial

open access: yes
British Journal of Haematology, Volume 207, Issue 6, Page 2592-2596, December 2025.
Anthony S. Stein   +7 more
wiley   +1 more source

Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow‐up subgroup analysis of the BOSTON trial

open access: yesEuropean Journal of Haematology, Volume 113, Issue 2, Page 242-252, August 2024.
Abstract Objectives To analyze the impact of prior therapies on outcomes with selinexor, bortezomib, and dexamethasone (SVd) versus bortezomib and dexamethasone (Vd) in 402 patients with relapsed/refractory multiple myeloma (RRMM) in the phase 3 BOSTON trial.
Maria‐Victoria Mateos   +10 more
wiley   +1 more source

Spray skin protectant versus standard moisturiser in the prevention of radiodermatitis in patients with anal canal and rectal cancer: A randomised clinical trial

open access: yesInternational Wound Journal, Volume 21, Issue 8, August 2024.
Abstract The evidence on products for the prevention of radiodermatitis is limited. The primary objective was to analyse the effectiveness of the spray skin protectant ‘non‐burning barrier film’ in the prevention of radiodermatitis with moist desquamation in patients with the anal canal and rectal cancer followed in nursing consultations compared to a ...
Fabiana Verdan Simões   +10 more
wiley   +1 more source

Exploring the Role of Central Metals in Bulky Phthalocyanines for Dye‐Sensitized Solar Cells

open access: yesChemistry – A European Journal, Volume 30, Issue 37, July 2, 2024.
A series of metallo‐(Zn(II), Mg(II) and Ru(II)) and free‐base phthalocyanines (Pcs) with a carboxyl anchoring group and either tert‐butyl or bulky 2,6‐diisopropylphenoxy peripheral substituents were synthesized and tested as sensitizer in DSSCs to shed light on the role of central metals in photovoltaic performance.
Ismael López‐Duarte   +6 more
wiley   +1 more source

Diuretics in pregnancy: Data from the ESC Registry of Pregnancy and Cardiac disease (ROPAC)

open access: yesEuropean Journal of Heart Failure, Volume 26, Issue 7, Page 1561-1570, July 2024.
Outcomes of the Registry of Pregnancy and Cardiac disease (ROPAC) regarding diuretic use during pregnancy. Data in n (%) unless otherwise specified. CI, confidence interval; LMIC, low‐or‐middle‐income country; LVEF, left ventricular ejection fraction; MACE, major adverse cardiac event (combined endpoint of maternal mortality, heart failure, arrhythmia,
Johanna A. van der Zande   +12 more
wiley   +1 more source

Bases regulatórias para a avaliação da segurança de medicamentos à base de nanotecnologia

open access: yesVigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia, 2020
Introdução: A nanotecnologia é uma tecnologia transdisciplinar que está sendo desenvolvida e aplicada em diversas áreas, dentre as quais cabe ressaltar a da saúde, principalmente no que tange à terapêutica e ao diagnóstico.
Juliana Palermo Tobler   +1 more
doaj   +4 more sources

Home - About - Disclaimer - Privacy